Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
21 12월 2022 - 9:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of December 2022
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Celyad Oncology SA
On December 21, 2022, Celyad Oncology SA (the Company) issued a press release providing an update on its strategic business model,
clinical trial program, and anticipated milestones for 2023. A copy of the Companys press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information contained in this Current Report on Form 6-K, including Exhibit 99.1 is hereby incorporated by
reference into the Companys Registration Statements on Forms F-3 (File No. 333-248464) and S-8 (File No. 333-220737).
EXHIBITS
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA |
|
|
|
|
Date: December 21, 2022 |
|
|
|
By: |
|
/s/ Michel Lussier |
|
|
|
|
|
|
Michel Lussier |
|
|
|
|
|
|
Interim Chief Executive Officer |
Celyad (CE) (USOTC:CLYYF)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Celyad (CE) (USOTC:CLYYF)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Celyad SA (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Celyad Oncology Sa News Articles